Endeavor

Are Cancer Patients Responding to the COVID Vaccine?

Moffitt study shows patients with myeloid malignancies do develop antibodies after vaccination

New Combo Therapy May Be a Better Option for Patients with Specific Mutation

Adding eprenetapopt to a standard MDS treatment shows promise in patients with TP53 mutations

Can UltraCAR-T™ Treat Myeloid Malignancies?

New type of CAR T therapy gets engineered cells to patients quicker

CAR T Brings Hope for Leukemia Patients, Challenges for Researchers

Phase 1 THINK study laid important groundwork for future CAR T trials

New Combination Therapy Shows Promise for Leukemia Patients

Early phase trial finds magrolimab plus chemotherapy effective in acute myeloid leukemia patients

‘I Spent A Decade Battling Cancer’

How one young woman thrived despite three separate cancer diagnoses

The Milestones Behind Miles for Moffitt

How three friends sparked an annual tradition for thousands Social Caption: In 15 years, Miles for Moffitt has become a staple in the Tampa Bay community, raising more than $6.4 million for cancer re

Rethinking Cellular Immunotherapy

Moffitt study uses CAR T therapy to treat side effects of cancer therapy

Sister, Sister

Bonds beyond DNA help sisters through transplant at Moffitt